Northview LifeSciences
VC Fund
Vancouver, Canada
Northview LifeSciences is a VC fund in Vancouver focused on Health Care and Fitness. NorthView Ventures is a strategic investment and consulting firm specialized the life sciences sector.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Northview LifeSciences invests in
Stages Northview LifeSciences invests in
Countries Northview LifeSciences invests in
Investment Focus
Industry
- Health Care 4 (33%)
- Fitness 2 (17%)
- Wellness 2 (17%)
- Biotechnology 2 (17%)
- Medical Device 2 (17%)
Stage
- Seed 4 (33%)
- Series A 3 (25%)
- Venture - Series Unknown 3 (25%)
- Series B 1 (8%)
- Series G 1 (8%)
Country
- Canada 4 (33%)
- United States 3 (25%)
- United Kingdom 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Varo Bank
|
Varo Money is driven by a mission to redefine banking so it’s easy for everyone to make smart choices with their money. In one mobile app, Varo offers customers no-cost premium bank accounts and high-interest savings accounts offered through The Bancorp Bank, and tech-first features to help people manage their money more easily.The company wasfounded in 2015 and is headquartered in San Francisco, California. | $123.9M / Series G / Feb 02, 2026 | |
The Medical Aesthetics Group
|
The Mcompany is a medical aesthetics consultancy provides tailored business plans and recruitment services. | Seed / Jan 01, 2024 | |
Amp Human
|
Amp Human is a venture-backed startup based in Park City, Utah dedicated to creating a new and trusted category of products to help humans push their limits. They have a platform technology born in biotech that carries nutrients through the skin to overcome one of the greatest limiting factors in human optimization, the gut. | $32.1M / Venture - Series Unknown / Nov 16, 2023 | |
Abdera Therapeutics
|
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers. Its targeted radiotherapies utilize purpose-built vectors to specifically target high-energy radio-isotopes to tumors and metastatic cancer lesions. This new class of drugs holds tremendous untapped therapeuticand commercial potential, and has generated over $10B in recent M&A, financings, and product launches – and are expected to comprise 70% of the $30B nuclear medicine market by 2030.It was launched by adMare BioInnovations, Canada’s global life sciences venture, in partnership with industry leaders AbCellera, and some of the country’s most successful scientist entrepreneurs. | $142M / Series B / Apr 20, 2023 | |
MindMics
|
MindMics is an emerging wearable company revolutionizing the information they can understand about the inner workings of our bodies and health. They hears every heartbeat to capture clinically meaningful biometrics accurately within real-time to unleash mental performance. | Venture - Series Unknown / Jan 01, 2023 | |
ARTAH
|
ARTAH manufactures supplements like vitamins, minerals, phytonutrients, and botanicals. | Seed / Jan 01, 2023 | |
|
Deep Surface AI Inc.
|
Developer of healthcare software designed to offer three-dimensional imaging services. | Venture - Series Unknown / Jan 01, 2023 | |
Total Flow Medical
|
Total Flow Medical is a medical device startup with a goal to extend and improve the quality of life for cardiac surgery and life support patients. | Seed / May 06, 2022 | |
|
Abdera Therapeutics
|
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers. Its targeted radiotherapies utilize purpose-built vectors to specifically target high-energy radio-isotopes to tumors and metastatic cancer lesions. This new class of drugs holds tremendous untapped therapeuticand commercial potential, and has generated over $10B in recent M&A, financings, and product launches – and are expected to comprise 70% of the $30B nuclear medicine market by 2030.It was launched by adMare BioInnovations, Canada’s global life sciences venture, in partnership with industry leaders AbCellera, and some of the country’s most successful scientist entrepreneurs. | Series A / Jan 01, 2022 | |
Elevate Farms
|
Elevate Farms’ solution uses hydroponics, automation, and photobiology to grow leafy greens in a climate-controlled environment. The solution aims to deliver a product that is larger, tastes better, and is more nutritional, at a lower cost than other methods. | $10M / Seed / May 18, 2020 | |
| See all 12 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Northview LifeSciences invest in?
Northview LifeSciences invests primarily in Health Care, Fitness and Wellness startups, most often at Seed and Series A stage. Most of the 12 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Northview LifeSciences last invest?
The most recent investment recorded for Northview LifeSciences closed in Feb 2026. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
